Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Chemical modification or the reaction product thereof – e.g.,...
Reexamination Certificate
2007-04-11
2010-02-23
Saoud, Christine J (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Chemical modification or the reaction product thereof, e.g.,...
C530S399000, C530S350000, C435S069400, C536S023500
Reexamination Certificate
active
07667008
ABSTRACT:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) fusion polypeptides.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4970154 (1990-11-01), Chang
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5234784 (1993-08-01), Aslam et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5557032 (1996-09-01), Mak
patent: 5589362 (1996-12-01), Bujard et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5672510 (1997-09-01), Eglitis et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5679559 (1997-10-01), Kim et al.
patent: 5811234 (1998-09-01), Roninson et al.
patent: 6150098 (2000-11-01), Zhang
patent: 6639063 (2003-10-01), Edwards
patent: 6716626 (2004-04-01), Itoh
patent: 7259248 (2007-08-01), Itoh et al.
patent: 7408047 (2008-08-01), Thomason et al.
patent: 7459540 (2008-12-01), Thomason et al.
patent: 2001/0012628 (2001-08-01), Agarwal et al.
patent: 2007/0128619 (2007-06-01), Itoh
patent: 2007/0238657 (2007-10-01), Itoh
patent: 0036676 (1981-09-01), None
patent: 0058481 (1982-08-01), None
patent: 0088046 (1983-09-01), None
patent: 0133988 (1985-03-01), None
patent: 0143949 (1985-06-01), None
patent: 0154316 (1985-09-01), None
patent: 0401384 (1990-12-01), None
patent: 0505500 (1992-09-01), None
patent: 91/09955 (1991-07-01), None
patent: 91/10425 (1991-07-01), None
patent: 91/10470 (1991-07-01), None
patent: 93/15722 (1993-08-01), None
patent: 94/20069 (1994-09-01), None
patent: 94/28122 (1994-12-01), None
patent: 95/05452 (1995-02-01), None
patent: 95/34670 (1995-12-01), None
patent: 96/37609 (1996-11-01), None
patent: 96/40958 (1996-12-01), None
patent: 96/41865 (1996-12-01), None
patent: 97/31899 (1997-09-01), None
patent: 00/54813 (2000-09-01), None
patent: 01/18209 (2001-05-01), None
patent: 01/32678 (2001-05-01), None
patent: 01/36640 (2001-05-01), None
patent: 01/38357 (2001-05-01), None
patent: 01/49849 (2001-07-01), None
Bork, 2000, Genome Research 10:398-400.
Brenner, 1999, Trends in Genetics 15: 132-133.
Bork et al., 1996, Trends in Genetics 12:425-427.
Ngo et al., 1994, The protein Folding problem and -tertiary Structure prediction, pp. 492-495.
Galzie et al. (Biochem. Cell Biol. 75: 669-685, 1997).
Polejaeva et al., Theriogenology, vol. 53, pp. 117-126, 2000.
Rulicke et al., Experimental Physiology, 65, 6:589-601, 2000.
Bishop, Repro. Nutr. Dev., 36: 607-618, 1996.
Skolnick et al., “From genes to protein structure and function: novel applications of computational approaches in teh genomic era.”, pp. 34-39, 2000.
“Go hunting in sequence databases but watch out for the traps.” vol. 12 No. 10, pp. 425-427, 1996.
“Protein annotation; defective work for function prediction.” vol. 14, No. 6, 1998.
Faham et al. (1998), “Diversity does make a difference: fibroblast growth factor-heparin interactions,” Curr. Opin. Struct. Biol. 8(5): 578-86.
GenBank Acc. No. AQ175436, Sep. 21, 1998, accessed Nov. 18, 2005.
GenBank Acc. No. AV050323, Jun. 16, 1999, accessed Nov. 18, 2005.
GenBank Acc. No. BAA99415, Aug. 3, 2000.
GenBank Acc. No. BAA99416, Jul. 11, 2000.
GenBank Acc. No. NP—061986, Apr. 6, 2003.
GenBank Acc. No. Q9NSA1, Oct. 1, 2000.
Ghielli et al. (1998), “Regeneration processes in the kidney after acute injury: role of infiltrating cells.” Exp. Nephrol. 6: 502-507.
Goldfarb (1996), “Functions of fibroblast growth factors in vertebrate development,” Cytokine Growth Factor Rev. 7(4): 311-325.
Hull et al (1997), “Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration,” Gut 40: 204-10.
Hsu et al. (1999), “Heparin Is Essential for a Single Keratinoctye Growth Factor Molecule To Bind and Form a Complex with Two Molecules of the Extracellular Domain of Its Receptor,” Biochemistry 38: 2523-34.
Hu et al., (1998), “FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation,” Mol. Cell. Biol. 18(10): 6063-6074.
Itoh and Ornitz (2004), “Evolution of the FGF and FGFR gene families.” Trends in Genetics 20(11): 563-569.
Kaufman et al. (1999), “Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome.” Blood 94: 3178-3184.
Kennell (1971), “Principles and practices of nucleic acid hybridization,” Progr. Nucl. Acid Res. Mol. Biol. 11: 259-301.
Kurosu et al. (2007), “Tissue-specific Expression of Klotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21.” J. Biol. Chem. 282(37): 26687-26695.
Ledley (1996), “Pharmaceutical Approach to Somatic Gene Therapy.” Pharm. Res. 13(11): 1595-1614.
Liu et al. (2007), “FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate.” Dev. Biol. 302: 80-91.
Mahairas et al. (1999), “Sequence-tagged connectors: a sequence approach to mapping and scanning the human genome.” PNAS 96(17): 9739-9744.
Mikkelsen (1993), “Interpreting sequence motifs: a cautionary note,” Trends Genet. 9(5): 15.
Nakamura et al. (1995), “The murine lymphotoxin-beta receptor cDNA: isolation by the signal sequence trap and chromosomal mapping,” Genomics 30(2): 312-19.
Niyogi (1969), “The influence of chain length and base composition on the specific association of oligoribonucleotides with denatured deoxyribonucleic acid,” J. Biol. Chem. 244(6): 1576-81.
Phillips (2001), “The challenge of gene therapy and DNA delivery.” J. Pharm. Pharmacology 53: 1169-1174.
Plotnikov et al. (2000), “Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity,” Cell 101: 413-24.
Wang et al. (1999), “Rapid analysis of gene expression (RAGE) facilitates universal expression profiling.” Nuc. Acids Res. 27: 4609-4618.
Verma et al. (1997), “Gene therapy—promises,problems and prospects.” Nature 389: 239-242.
Smith et al., “The challenges of genome sequence annotation or the devil in the details.” pp. 1222-1223, vol. 15, 1997.
Bork et al., “Powers and pitfalls in sequence analysis: The 70% hurdle.” pp. 398-400, 2000.
Gaizie et al., “Fibroblast growth factors and their receptors.” pp. 669-685, 1997.
Bork et al,. “Predicting functions from the protein sequences-where are the bottlenecks?” pp. 313-318, vol. 18, 1998.
Ngo et al., “Computational complexity, protein structure prediction, and the leventhal paradox.” pp. 491-495, 1994.
Accession Number: AB006136, Aug. 27, 1997, XP002165898.
Smallwood, P.M. et al., “Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. ”, PNAS USA, vol. 93, pp. 9850-9857 Sep. 1996.
The ADHR Consortium, “Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.”, Nature Genetics, 26:345-348, 2000.
Econs and McEnry, “Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.” J. Clin. Endocrinol. Metab., 82:674-681, 1997.
Nishimura et al., “Identification of a novel FGF, FGF-21, preferentially expressed in the liver (1
Liu Benxian
Thomason Arlen
Amgen Inc.
McDonnell Boehnen & Hulbert & Berghoff LLP
Saoud Christine J
LandOfFree
Fibroblast growth factor-like polypeptides and variants thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibroblast growth factor-like polypeptides and variants thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor-like polypeptides and variants thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4156622